Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (137) Full Text Articles (6313) Focus on Renal

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

181 WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation Gynecologic Oncology, May 22, 2013 Clinical Article

182 Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma Full Text World Journal of Gastroenterology, May 22, 2013 Review Article

183 Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer Full Text World Journal of Gastroenterology, May 22, 2013 Review Article

184 Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool Patient Education and Counselling, May 22, 2013 Review Article

185 BAALC and WT1 expression from diagnosis to hematopoietic stem cell transplantation: Consecutive monitoring in adult patients with core-binding factor-positive AML European Journal of Haematology, May 22, 2013 Clinical Article

186 Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen European Journal of Haematology, May 22, 2013 Clinical Article

187 Prognostic role of immunohistochemical analysis of 5mc in Myelodysplastic Syndromes European Journal of Haematology, May 22, 2013 Clinical Article

188 The Effect of tumor subsite on short-term outcomes and costs of care after oral cancer surgery The Laryngoscope, May 22, 2013 Clinical Article

189 Prognostic value of survivin expression in breast cancer patients: a meta-analysis Tumor Biology, May 22, 2013 Evidence Based Medicine Review Article

190 Practical aspects of genetic counseling in breast cancer: Lights and shadows The Breast, May 22, 2013 Review Article

191 Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: Risk factors and trends in outcomes Journal of Surgical Oncology, May 22, 2013 Review Article

192 Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients Hematology, May 22, 2013 Clinical Article

193 Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia Hematology, May 22, 2013 Clinical Article

194 The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes Hematology, May 22, 2013 Clinical Article

195 Methylation status of CEBPA gene promoter in chronic myeloid leukemia Hematology, May 22, 2013 Clinical Article

196 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 22, 2013 Clinical Article

197 Patient-specific microRNA expression profiles as a marker for minimal residual disease in acute myeloid leukemia Hematology, May 22, 2013 Clinical Article

198 D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine Hematology, May 22, 2013 Clinical Article

199 Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT Bone Marrow Transplantation, May 22, 2013 Clinical Article

200 Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT Bone Marrow Transplantation, May 22, 2013 Clinical Article

50 available pages First Previous 10 11 12 13 14 15 16 17 18 19 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Oncology News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology